Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.74 CHF | -1.28% | -0.26% | +57.58% |
Mar. 19 | Newron Pharmaceuticals S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Transcript : Newron Pharmaceuticals S.p.A., 2023 Earnings Call, Mar 19, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+57.58% | 161M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.68% | 31.45B | |
+44.30% | 23.35B | |
-8.75% | 16.72B | |
-25.64% | 15.09B | |
-9.43% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |
- Stock
- Equities
- Stock Newron Pharmaceuticals S.p.A. - Swiss Exchange
- News Newron Pharmaceuticals S.p.A.
- Newron Pharmaceuticals S p A : FY20 Loss Widens to $23 Million